Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.
Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.
复制标题
波士顿乳房 X 线摄影队列研究中，年龄、种族和家族史对乳腺癌筛查中与 COVID-19 相关的变化的影响。
DOI：
10.1007/s10549-023-07083-y
复制
发表时间：
2023
影响因子：
3.8
通讯作者：
Warner,EricaT
中科院分区：
文献类型：
--
作者：
Chen,Naiyu;Cheng,David;Sodipo,MichelleO;Barnard,MollieE;DuPre,NatalieC;Tamimi,RullaM;Warner,EricaT
研究目的：我们对参加波士顿乳房X线摄影队列研究的妇女进行了研究，以调查年龄、种族、在COVID-19封锁期间，有乳腺癌家族史的妇女在筛查或诊断成像率方面经历了差异，在重新开放期间，这些比率的发生率反弹较慢。COVID-19（2019年1月至2020年2月），封锁（2020年3月至5月），以及重新开放期间（2020年6 - 12月），并按年龄检验了同一时期内每月发病率的差异（< 50 vs ≥ 50），人种（白色vs非白色）和一级乳腺癌家族史结果总体而言，我们观察到三个时间段（COVID-19前，封锁和重新开放）的乳腺癌筛查和诊断成像率下降。在COVID-19之前（2019年1月至2020年2月），年龄≥ 50岁的女性的乳腺癌筛查率每月发生率高出5%（p= 0.005），但在重新开放阶段（2020年6月至12月），比年龄< 50岁的女性低19%（p< 0.001）。白色参与者乳腺癌诊断成像率的月发病率比非白人参与者高36%（p= 0.018）。随着COVID-19的持续复苏，必须密切关注，以确保公平地恢复护理。
PurposeWe studied women enrolled in the Boston Mammography Cohort Study to investigate whether subgroups defined by age, race, or family history of breast cancer experienced differences in the incidence of screening or diagnostic imaging rates during the COVID-19 lockdown and had slower rebound in the incidence of these rates during reopening.MethodsWe compared the incidence of monthly breast cancer screening and diagnostic imaging rates over during the pre-COVID-19 (January 2019–February 2020), lockdown (March–May 2020), and reopening periods (June–December 2020), and tested for differences in the monthly incidence within the same period by age (< 50 vs ≥ 50), race (White vs non-White), and first-degree family history of breast cancer (yes vs no).ResultsOverall, we observed a decline in breast cancer screening and diagnostic imaging rates over the three time periods (pre-COVID-19, lockdown, and reopening). The monthly incidence of breast cancer screening rates for women age ≥ 50 was 5% higher (p= 0.005) in the pre-COVID-19 period (January 2019–February 2020) but was 19% lower in the reopening phase (June–December 2020) than that of women aged < 50 (p< 0.001). White participants had 36% higher monthly incidence of breast cancer diagnostic imaging rates than non-White participants (p= 0.018).ConclusionThe rebound in screening was lower in women age ≥ 50 and lower in non-White women for diagnostic imaging. Careful attention must be paid as the COVID-19 recovery continues to ensure equitable resumption of care.